Sunflower Pharmaceutical Group Co (SZSE:002737) Ending Cash Position : ¥938 Mil (As of Mar. 2025)

View and export this data going back to 2014. Start your Free Trial

What is Sunflower Pharmaceutical Group Co Ending Cash Position?

Sunflower Pharmaceutical Group Co's Ending Cash Position for the quarter that ended in Mar. 2025 was ¥938 Mil.

Sunflower Pharmaceutical Group Co's quarterly Ending Cash Position declined from Sep. 2024 (¥1,198 Mil) to Dec. 2024 (¥1,038 Mil) and declined from Dec. 2024 (¥1,038 Mil) to Mar. 2025 (¥938 Mil).

Sunflower Pharmaceutical Group Co's annual Ending Cash Position declined from Dec. 2022 (¥2,398 Mil) to Dec. 2023 (¥2,286 Mil) and declined from Dec. 2023 (¥2,286 Mil) to Dec. 2024 (¥1,038 Mil).

Sunflower Pharmaceutical Group Co Ending Cash Position Historical Data

The historical data trend for Sunflower Pharmaceutical Group Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sunflower Pharmaceutical Group Co Ending Cash Position Chart

Sunflower Pharmaceutical Group Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Ending Cash Position

Get a 7-Day Free Trial

1,647.91

1,314.09

2,398.42

2,285.71

1,037.96

Sunflower Pharmaceutical Group Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Ending Cash Position	Get a 7-Day Free Trial															3,495.68	1,703.85	1,198.00	1,037.96	937.73

Sunflower Pharmaceutical Group Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Sunflower Pharmaceutical Group Co's Ending Cash Position for the fiscal year that ended in Dec. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	2285.705	+	-1247.744
	=	1,038

Sunflower Pharmaceutical Group Co's Ending Cash Position for the quarter that ended in Mar. 2025 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	1037.96	+	-100.23
	=	938

Sunflower Pharmaceutical Group Co Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Sunflower Pharmaceutical Group Co's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Sunflower Pharmaceutical Group Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sunflower Pharmaceutical Group Co Ltd (SZSE:002737) » Definitions » Ending Cash Position

Traded in Other Exchanges

N/A

Address

Welcome Road, 18 East Lake Road, Harbin High-Tech Industrial Development Zone, Harbin, Heilongjiang, CHN

Website

http://www.kuihuayaoye.com

Sunflower Pharmaceutical Group Co Ltd is engaged in pharmaceutical manufacturing, marketing, and scientific research. The company's product profile include Honeysuckle, Weikangling Granules, Autumn pear moisturizing cream, Vitamin AD drops, Pediatric paracetamol granules, Jianweixiaoshi tablets, Pediatric Chai Gui Antipyretic Granules, Pediatric cough syrup, Kang Fu anti-inflammatory suppository, Xiangsha Yangwei Pills, and others.

Executives

Zhou Jian Zhong	Executives
Liu Tian Wei	Director
Guan Yu Xiu	Director
Wu Guo Xiang	Executives
Ren Jing Shang	Directors, executives
Guan Yan Bin	Directors, executives
Wan Yun Guo	Executives
Tian Yan	Secretary Dong
Tan Chang	Executives
Zhang Quan	Director
Xu Qing Fen	Supervisors
Jiang Feng He	Supervisors
Wu Shu Hua	Director
Guan Yan Ling	Director

Sunflower Pharmaceutical Group Co Headlines

No Headlines